Lucion
Lucion is an influential professional venture capital institute.
Business Model:
Revenue: $22M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Lucion Information
Geographic Data
Address: Jingshi Road 9999
City:
State: shanghai municipality
Zip: 250101
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lucion is an influential professional venture capital institute.
Contact Phone:
Contact Email:
Lucion went public on 12/25/1996 on the SSE
Listed Exchange:
SSE
IPO Date:
12/25/1996
Ticker Symbol:
600783
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2017 | CloverSec Labs | Series A | 10.3M |
| 8/2014 | KungFu Animation Group | Angel Round | 488.1k |
| 12/2021 | ABclonal | Series D | 0 |
| 3/2020 | Targene Medical | Series A | 0 |
| 10/2020 | 3D Medicines | Private Equity Round | 0 |
| 6/2013 | Huashi Jingcheng | Angel Round | 487.4k |
| 1/2022 | SiBionics | Series C | 0 |
| 3/2018 | XGIMI | Corporate Round | 95M |
| 1/2020 | 3D Medicines | Venture Round | 0 |
| 11/2018 | Airwing.ai | Series A | 2.9M |
| 4/2016 | BayNexus | Series B | 3.1M |
| 12/2010 | Hoteam Software | Angel Round | 454.5k |
| 5/2022 | HemaCell | Series A | - |
| 2/2021 | ABclonal | Series C | 0 |
| 10/2014 | DAYANG PARKING | Series B | 3.3M |
| 1/2019 | LandSpace | Series B | 14.5M |
| 1/2023 | Meidong Huicheng | Venture Round | - |
| 10/2019 | WeMed | Series C | - |
| 4/2021 | WeMed | Series D | 46.2M |
| 12/2019 | Remegen | Private Equity Round | - |
| 4/2020 | APTBIO | Series A | 28.3M |
| 4/2019 | Ruiyi Biotechnology (Realbio Technology) | Series A | 15M |
| 8/2017 | Zhimai Yinqing | Seed Round | 1.5M |
| 1/2023 | Insyce | Series B | 21.8M |
| 5/2022 | HemaCell | Series A | - |
| 1/2022 | SiBionics | Series C | 0 |
| 12/2021 | ABclonal | Series D | 0 |
| 4/2021 | WeMed | Series D | 0 |
| 2/2021 | ABclonal | Series C | 0 |
| 10/2020 | 3D Medicines | Private Equity Round | 0 |
| 4/2020 | APTBIO | Series A | 0 |
| 3/2020 | Targene Medical | Series A | 0 |
| 1/2020 | 3D Medicines | Venture Round | 0 |
| 12/2019 | Remegen | Private Equity Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
